An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles privately for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Express Worries
Nevertheless, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting substances of uncertain source.
Some experts said the popularity for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.
Service Response and Content Elimination
Based on TikTok, the platform has taken down problematic content and prohibited associated hashtags and query recommendations. The company stated it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or injecting at residence.
Within minutes of joining one community, a seller posted contact information, where most transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, health issues or previous experience.
Item Details and Costs
Within these communities, messages display dark colored parcels with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how long a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these online products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her staff has previously encountered individuals injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to possibly serious health risks”.
